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CMR and 2D echocardiographic assessment of cardiac volumes, mass and
function. 
Results Among 14 patients (mean age 80.2±8.7 Y [66-91]), a good cor-
relation was found between echocardiography and CMR for LVEF
(56.7±8.1% vs 54.3±9.2%, r=0.8). Echocardiography mildly underesti-
mated LV end diastolic volume (EDV) (55.6±25.8 vs 67±24.1mL/m2,
r=0.84) and end systolic volume (ESV) (24.9±15.8 vs 31.3±13.9mL/m2
r=0.66). Echocardiography overestimated the LV mass (87.4±23.5 vs
64±22.3g/m2, r=0.5). Left atrial volume (assessed by CMR) was increased
(52.8±24.9mL/m2), 8 patients had atrial fibrillation with larger left atrial
volume (71.5±26.9 vs 38.8±10.9mL/m2 for sinus rhythm, p 0.008). Right
ventricular (RV) EDV and ESV assessed by CMR were normal. Mean
RVEF was 43.7±8.7% and RVEF was <45% in 8 (57%) patients who also
had lower LVEF (p=0.005) and higher pulmonary artery systolic pressure
(p=0.01). Late gadolinium enhancement (LGE) was found in 8 cases, 4
with mid-wall LGE, 2 with subendocardial or transmural LGE and 2 with
sub epicardial LGE. 
Conclusion CMR was feasible, safe and was a useful complement to echo-
cardiography in elderly patients hospitalized for HFpEF. In this population,
LVEF assessed by CMR and echocardiography were comparable. Echocardi-
ography underestimated LV volumes and overestimated LV mass. Risk factors
for adverse outcome such as RV dysfunction and the presence of LGE were
found in more than half of the cases. 
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Cardiac disease occurs in more than 50% of patients with idiopathic
hypereosinophilic syndrome; it is the major cause of morbidity and mor-
tality in patients with this syndrome. The overall mortality is high if
untreated. We aim to rapport recent experience in these cardiac diseases,
especiall echographic features and the contribution of multimodalities
imaging.
This retrospective, descriptive and multicenter study reports the findings of
patients in cardiac centers of Marseille, Montpellier and Rennes between Sep-
tember 2008 and March 2014. Echographic, MRI cardiac, coronarographic,
PET CT, biology and histologic findings are reported. Seven patients have
been reported. Echocardiography is the reference diagnostic method. Classical
findings are progressive endomyocardial thickening, apical obliteration of one
or both ventricles by echogenic material suggestive of fibrosis or thrombus
formation, posterior mitral leaflet involvement and papillary dysfunction
resulting in severe mitral regurgitation. These features are involved in embolic
events or heart failure. MRI helps refine the diagnosis. The characteristic irre-
versible stage shows a circumferential thickened fibrotic sub endocardium
with wall thrombi. The CT identifies non ischemic thrombus excluding coro-
nary artery disease by coronary imaging. Coronary angiography may reveal
fibrosis by the smoothed appearance of the ventricular walls and apical filling.
PET CT shows general signs of myocarditis, such as myocyte necrosis, in the
first stage of the disease.
Symptomatic treatment can lead to cardiac surgery (mitral valve
replacement, resection of endomyocardial fibrosis). Each imaging tech-
nique plays a role in each of the three stages of the disease and the typical
features of myocarditis, thrombus or fibrosis must be identified. Only
seven cases of this rare disease have been identified in three french cardiac
centers since 2008; this too small sample does not allow us to draw statis-
tical conclusions.
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Purpose Transthoracic echocardiography (TTE) for Ebola virus disease
(EVD) might contribute to evaluate gravity, guide treatment, and finally
improve prognosis and has not previously been described. This report delin-
eates the safety, feasibility and clinical implications of systematic TEE for
patients with EVD, in the setting of a deployed French military Ebola virus
disease Treatment Center in Guinea.
Methods In first 48 hours after admission for EVD, a TTE was performed.
All patients were monitored by continue video survey and radio call. Data
were collected prospectively on all cases to include TTE hemodynamic
parameters, and evaluate EVD cardiac complications. Data were collected by
in-live oral transmission to medical center, and correlated to blood test vari-
ables including I-Troponin and Brain Natriuretic Peptide.
Result Eight consecutive patients, hospitalized in March 29th underwent
TTE evaluation performed by a cardiologist during the first 48 hours of
admission. Mean time in Personal Protective Equipment (PPE) was
82 min. No virus accidental exposition during procedure was deplored.
TTE were feasible for all patients and all parameters could be studied. All
TTE showed signs of hypovolemia with low LV pressure filled despite
2 patients with dyspnea; 1 patient had pericarditis effusion (with inappro-
priate sinus bradycardia and elevated troponin), and 1 had previous aspect
of ischemic cardiomyopathy with conserved left ventricular ejection frac-
tion (LVEF).
Conclusion Early use of TTE in Ebola virus disease is safe, effective
and facilitates patient care. It should be considered a feasible additional
exam, where physician expertise and resources allow. In our study,
contrary to the hypotheses previously made, dyspnea had a non-hemody-
namic origin (figure next page).
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